Omicron, a new SARS-CoV-2 variant: assessing the impact on severity and vaccines efficacy

The reply letter has been put forth in response to the comment made by Karthyayani Priya Satish entitled “India and the COVID-19 Vaccine.” The comment was made in context to our published work “Exploring the covid-19 vaccine candidates against SARS-CoV-2 and its variants: where do we stand and where...

Full description

Bibliographic Details
Published in:	Human Vaccines & Immunotherapeutics
Main Authors:	Gaurav Joshi, Ramarao Poduri
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2022-01-01
Subjects:	omicron sars-cov-2 covid-19 vaccine efficacy
Online Access:	http://dx.doi.org/10.1080/21645515.2022.2034458

Similar Items

Vaccination with Omicron Inactivated Vaccine in Pre-vaccinated Mice Protects against SARS-CoV-2 Prototype and Omicron Variants
by: Yuntao Zhang, et al.
Published: (2022-07-01)

Boosting with Omicron-specific mRNA vaccine or historical SARS-CoV-2 vaccines elicits discriminating immune responses against Omicron variants
by: Yi Wu, et al.
Published: (2025-02-01)

The SARS-CoV-2 Variant Omicron Is Able to Escape Vaccine-Induced Humoral Immune Responses, but Is Counteracted by Booster Vaccination
by: Florian D. Hastert, et al.
Published: (2022-05-01)

Retention of Neutralizing Response against SARS-CoV-2 Omicron Variant in Sputnik V-Vaccinated Individuals
by: Daniele Lapa, et al.
Published: (2022-05-01)

Exploring the COVID-19 vaccine candidates against SARS-CoV-2 and its variants: where do we stand and where do we go?
by: Gaurav Joshi, et al.
Published: (2021-12-01)

Vaccination Is Associated With Shorter Time to Target Cycle Threshold Value in Patients With SARS-CoV-2 Omicron Variant
by: Jiajun Wu, et al.
Published: (2022-07-01)

Is Booster Dose Strategy Sufficient for Omicron Variant of SARS-CoV-2?
by: Vivek P. Chavda, et al.
Published: (2022-02-01)

SARS-CoV-2 Omicron Variant Neutralization after Third Dose Vaccination in PLWH
by: Alessandra Vergori, et al.
Published: (2022-08-01)

An omicron-based vaccine booster elicits potent neutralizing antibodies against emerging SARS-CoV-2 variants in adults
by: Tao Li, et al.
Published: (2023-12-01)

In-Silico Analysis of Monoclonal Antibodies against SARS-CoV-2 Omicron
by: Ye-Fan Hu, et al.
Published: (2022-02-01)

SARS-CoV-2 Omicron Symptomatic Infections in Previously Infected or Vaccinated South African Healthcare Workers
by: Marta C. Nunes, et al.
Published: (2022-03-01)

Worldwide SARS-CoV-2 Omicron variant infection: Emerging sub-variants and future vaccination perspectives
by: Yu-An Kung, et al.
Published: (2025-07-01)

Sub‐lineages of the SARS‐CoV‐2 Omicron variants: Characteristics and prevention
by: Ailan Xu, et al.
Published: (2022-09-01)

The Epidemiological Features of the SARS-CoV-2 Omicron Subvariant BA.5 and Its Evasion of the Neutralizing Activity of Vaccination and Prior Infection
by: Dandan Tian, et al.
Published: (2022-10-01)

Incidence of SARS-CoV-2 Infection during the Omicron Variant Emergence in Southern Vietnam: Prior Infection versus Third-Dose Vaccination
by: Thang Thanh Phan, et al.
Published: (2022-10-01)

Homologous or heterogenous vaccination boosters enhance neutralizing activities against SARS‐CoV‐2 Omicron BA.1 variant
by: Zhongcheng Zhou, et al.
Published: (2022-06-01)

SARS-CoV-2 Vaccine Breakthrough Infections of Omicron and Delta Variants in Healthcare Workers
by: Elisa Regenhardt, et al.
Published: (2023-05-01)

Sustained applicability of SARS-CoV-2 variants identification by Sanger Sequencing Strategy on emerging various SARS-CoV-2 Omicron variants in Hiroshima, Japan
by: Chanroth Chhoung, et al.
Published: (2024-11-01)

Effectiveness of Bivalent Omicron-Containing Booster Vaccines against SARS-CoV-2 Omicron Variant among Individuals with and without Prior SARS-CoV-2 Infection
by: Kristin Widyasari, et al.
Published: (2023-08-01)

Analyzing the emerging patterns of SARS‐CoV‐2 Omicron subvariants for the development of next‐gen vaccine: An observational study
by: Ranjan K. Mohapatra, et al.
Published: (2023-10-01)

Molecular Basis of Host-Virus Interactions to Explain Relative Transmission and Severity Caused by Omicron and Delta variants of SARS-CoV-2
by: Vinod Joshi, et al.
Published: (2023-09-01)

New SARS-CoV-2 Omicron variant — clinical picture, treatment, prevention (literature review)
by: V. I. Vechorko, et al.
Published: (2022-07-01)

Effectiveness of COVID-19 vaccines against SARS-CoV-2 Omicron variants during two outbreaks from March to May 2022 in Quzhou, China
by: Zhiying Yin, et al.
Published: (2023-01-01)

Research progress on vaccine efficacy against SARS-CoV-2 variants of concern
by: Lianlian Bian, et al.
Published: (2022-11-01)

Clinical Progression and Outcome of Hospitalized Patients Infected with SARS-CoV-2 Omicron Variant in Shanghai, China
by: Jiasheng Shao, et al.
Published: (2022-08-01)

Effectiveness of inactivated COVID-19 vaccines against mild disease, pneumonia, and severe disease among persons infected with SARS-CoV-2 Omicron variant: real-world study in Jilin Province, China
by: Hongqin Xu, et al.
Published: (2023-12-01)

mRNA Booster Vaccination Enhances Antibody Responses against SARS-CoV2 Omicron Variant in Individuals Primed with mRNA or Inactivated Virus Vaccines
by: Biyan Zhang, et al.
Published: (2022-06-01)

Genomic Perspectives on the Emerging SARS-CoV-2 Omicron Variant
by: Wentai Ma, et al.
Published: (2022-02-01)

A booster dose of Delta × Omicron hybrid mRNA vaccine produced broadly neutralizing antibody against Omicron and other SARS-CoV-2 variants
by: I-Jung Lee, et al.
Published: (2022-07-01)

Correlation Analysis of Anti-SARS-CoV-2 RBD IgG and Neutralizing Antibody against SARS-CoV-2 Omicron Variants after Vaccination
by: Nuchjira Takheaw, et al.
Published: (2022-05-01)

Next generation sequencing of multiple SARS-CoV-2 infections in the Omicron Era
by: Marzia Cavalli, et al.
Published: (2025-01-01)

Mathematical Modeling of SARS-CoV-2 Omicron Wave under Vaccination Effects
by: Gilberto González-Parra, et al.
Published: (2023-02-01)

Genomic profile of SARS-CoV-2 Omicron variant and its correlation with disease severity in Rajasthan
by: Ravi P. Sharma, et al.
Published: (2022-09-01)

Impact of Vaccination and Public Health Measures on the Severity of SARS-CoV-2 Omicron Infections in China: A Systematic Review and Meta-Regression Analysis
by: Can Wang, et al.
Published: (2025-07-01)

Cross-protective immunity induced by omicron variant of SARS-CoV-2
by: Selia Chowdhury, et al.
Published: (2023-12-01)

Riding the Omicron BA.5 Wave: Improved Humoral Response after Vaccination with Bivalent Omicron BA.4-5-Adapted mRNA SARS-CoV-2 Vaccine in Chronic Hemodialysis Patients
by: Eugen Ovcar, et al.
Published: (2023-08-01)

Breakthrough infections with SARS-CoV-2 omicron efficiently boost antibodies from previous BNT162b2 vaccinations
by: Thomas Perkmann, et al.
Published: (2023-08-01)

Comparison of the disease severity with infection of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) Delta and Omicron variants: A meta‐analysis
by: Ying Qiu, et al.
Published: (2023-03-01)

The neutralizing response to SARS-CoV-2 Omicron variants BA.1 and BA.2 in COVID-19 patients and homologous and heterologous vaccinees
by: Francesca Dapporto, et al.
Published: (2022-11-01)

Omicron Variant Could Be an Antigenic Shift of SARS-CoV-2
by: Anju Kaushal
Published: (2025-05-01)